Press Release

Digital Respiratory Devices Market to Grow with a CAGR of 10.21% through 2030

Rising integration of AI and IoT in respiratory care devices for enhanced patient adherence and personalized treatment, along with expanding telemedicine services improving remote respiratory management, is expected to drive the Global Digital Respiratory Devices Market growth in the forecast period, 2026-2030

 

According to TechSci Research report, “Digital Respiratory Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Digital Respiratory Devices Market stood at USD 43.21 Billion in 2024 and is expected to reach USD 77.54 Billion by 2030 with a CAGR of 10.21% during the forecast period. The Global Digital Respiratory Devices Market has witnessed remarkable growth in recent years, driven by a combination of technological advancements, increasing respiratory disorders, and a growing awareness of the importance of respiratory health. Digital respiratory devices are revolutionizing the healthcare industry by providing patients and healthcare providers with innovative tools to monitor, manage, and improve respiratory conditions. One of the primary drivers of the Global Digital Respiratory Devices Market is the increasing prevalence of respiratory disorders worldwide. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and cystic fibrosis are on the rise, primarily due to factors like urbanization, pollution, smoking, and an aging population. As the number of individuals affected by these respiratory conditions grows, so does the demand for effective monitoring and management solutions, which digital respiratory devices are well-suited to provide.

Advancements in technology have played a pivotal role in the development of digital respiratory devices. Miniaturization, sensor technology, connectivity options, and improved algorithms have enabled the creation of devices that are more accurate, user-friendly, and capable of providing real-time data. These technological innovations enhance the overall patient experience and empower individuals to take a proactive approach to managing their respiratory healthDigital respiratory devices have ushered in a new era of patient empowerment and engagement. Patients now have access to a wealth of information about their respiratory health, allowing them to make informed decisions and actively participate in their treatment plans. This increased engagement can lead to better compliance with prescribed therapies, improved outcomes, and reduced healthcare costs in the long run.

The COVID-19 pandemic accelerated the adoption of telehealth and remote monitoring solutions. Digital respiratory devices, with their ability to transmit data to healthcare providers in real-time, have become invaluable tools in remote patient monitoring. This is especially important for individuals with chronic respiratory conditions who can now receive timely guidance and adjustments to their treatment plans without the need for frequent in-person visits. Digital respiratory devices also contribute to healthcare cost containment. By enabling proactive disease management and reducing the frequency of hospital admissions, these devices can significantly lower the overall healthcare expenditure associated with respiratory disorders. This cost-effectiveness is particularly attractive to healthcare systems and payers looking to optimize their resources.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Digital Respiratory Devices Market


The Global Digital Respiratory Devices Market is segmented into product, indication, distribution channel, regional distribution, and company.

Based on the Distribution Channel, Online Pharmacies emerged as the fastest growing segment in the Global Digital Respiratory Devices Market during the forecast period. This is driven by the increasing preference for online shopping, convenience, and the expanding digitalization of healthcare. With more consumers turning to e-commerce for purchasing medical products, online pharmacies offer a seamless platform for acquiring digital respiratory devices such as smart inhalers, CPAP machines, and monitoring equipment. These platforms provide easy access to a wide range of products, often at competitive prices, and deliver them directly to consumers' doorsteps, enhancing convenience. The growing awareness of respiratory conditions, such as asthma and sleep apnea, alongside the rising adoption of digital health tools, further fuels the demand for digital respiratory devices via online pharmacies. Additionally, the ongoing trend of telemedicine and remote healthcare monitoring has encouraged the use of e-commerce as a primary distribution channel. Online pharmacies offer timely delivery of devices and medications, ensuring that patients have continuous access to essential treatment tools.

Based on the Region, Asia-Pacific emerged as the fastest growing region in the Global Digital Respiratory Devices Market during the forecast period. This is driven by several factors that highlight the region's expanding healthcare landscape. The rising prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea, coupled with increasing air pollution levels, has created a substantial demand for advanced respiratory management solutions. Governments and healthcare organizations in the region are increasingly focusing on improving healthcare infrastructure and expanding access to innovative medical technologies, contributing to the growth of the digital respiratory devices market. The region's large population base, including significant urbanization and changing lifestyle habits, is further accelerating the adoption of digital health technologies. As more consumers in countries like China, India, and Japan turn to digital respiratory devices for better management of chronic conditions, the market continues to expand. Additionally, the increasing awareness of the benefits of remote monitoring and personalized healthcare solutions is driving the adoption of smart inhalers, CPAP machines, and other digital respiratory tools.

Furthermore, rising disposable incomes, advancements in telemedicine, and favorable government policies promoting healthcare technology adoption have created a conducive environment for market growth in Asia-Pacific. These factors collectively position the region as a key driver in the global digital respiratory devices market over the forecast period.


Major companies operating in Global Digital Respiratory Devices Market are:

  • COHERO Health Inc.
  • Cognita Labs llc
  • Adherium Limited
  • Amiko Digital Health Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • M Health Care Limited
  • AireHealth, Inc.


Download Free Sample Report

Customers can also request 10% free customization in this report


“The Global Digital Respiratory Devices Market is expanding due to the increasing collaboration between healthcare providers and technology companies to develop innovative respiratory solutions. As healthcare systems worldwide look to enhance patient care and optimize resource utilization, partnerships between medical device manufacturers and tech firms are facilitating the creation of advanced, data-driven respiratory devices. These collaborations leverage cutting-edge technologies, such as cloud computing and big data analytics, to offer personalized treatment options and real-time monitoring. By combining medical expertise with technological innovation, these partnerships are paving the way for more effective, efficient, and accessible respiratory care, thus driving the growth of the digital respiratory devices market.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

Digital Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Digital Respiratory Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Digital Respiratory Devices Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com


Relevant Reports

Digital Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others), By Indication (Asthma, COPD, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F

Healthcare | Mar, 2025

The increasing prevalence of respiratory diseases such as asthma and COPD, coupled with the growing adoption of smart inhalers and connected devices for real-time monitoring are the factors driving the Global Digital Respiratory Devices Market in the forecast period 2026-2030.

Relevant News